MONOGRAPH CAPITAL ADVISORS, L.P.
MONOGRAPH CAPITAL ADVISORS, L.P. is a Seed, Series A, Series B and Series C+ fund in the US and Europe investing in healthcare-tech and life-sciences.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- healthcare-tech, life-sciences
- Invests in
- US-wide, Europe
- Founded
- 2021
- Assets under management
- 154000000
- Website
- monograph.bio
Check size not disclosed
Thesis
The firm focuses on early-stage investments in life sciences, specifically therapeutics, diagnostics, and digitally-enabled healthcare, with a geographic scope spanning North America and Europe. Monograph Capital's investment strategy includes co-founding companies alongside scientists. As of March 2025, Monograph Capital raised approximately $154 million for its second fund, Monograph Capital Partners II, L.P..
Common questions
Does MONOGRAPH CAPITAL ADVISORS, L.P. invest at the Seed stage?
Yes. MONOGRAPH CAPITAL ADVISORS, L.P. lists Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does MONOGRAPH CAPITAL ADVISORS, L.P. invest?
MONOGRAPH CAPITAL ADVISORS, L.P. invests in the US and Europe.